Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy

Recruiting

Phase 2

Reactive Oxygen SpeciesTargeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy

Sponsor:

Massachusetts Eye and Ear Infirmary

Code:

NCT04440280

Conditions

Fuchs Endothelial Corneal Dystrophy

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

N-acetyl cysteine (NAC) 10% solution

N-acetyl cysteine (NAC) 20% solution

Visine Dry Eye Relief eye drops

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-24. This information was provided to ClinicalTrials.gov by Massachusetts Eye and Ear Infirmary on 2024-06-20.